{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:06:11Z","timestamp":1780463171285,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007594","name":"Comenius University in Bratislava","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune-mediated cerebellar ataxias lack dynamic biomarkers that reflect systemic metabolic changes during treatment. In this longitudinal case of anti-GAD65 cerebellar ataxia, high-resolution respirometry of peripheral blood mononuclear cells (PBMCs) revealed treatment-associated shifts in mitochondrial bioenergetic organization that occurred in temporal association with clinical improvement. A 61-year-old woman presented with a 6-month history of progressive gait instability, downbeat nystagmus, dysarthria. Diagnostic workup revealed a highly elevated anti-GAD65 antibody index (&gt;\u2009400.0), while brain MRI and routine cerebrospinal fluid analysis were unremarkable, confirming a diagnosis of anti-GAD-associated cerebellar ataxia. Serial high-resolution respirometry was used to assess PBMC mitochondrial function at baseline and following successive therapies. At baseline, the patient exhibited a Complex I\u2013dominant profile with suppressed Complex II activity, reduced glycerophosphate dehydrogenase (GpDH) flux, and impaired mitochondrial coupling. While corticosteroids yielded negligible metabolic or clinical changes, subsequent plasmapheresis was followed by increased Complex II and GpDH flux, normalized coupling parameters, and expanded respiratory reserve. These bioenergetic shifts paralleled significant clinical recovery, as evidenced by a reduction in the Scale for the Assessment and Rating of Ataxia (SARA) score from 17 to 12, and were further accompanied by a decrease in the anti-GAD65 antibody index. This case suggests that PBMC mitochondrial bioenergetics may reflect systemic metabolic changes during treatment in anti-GAD ataxia. These observations provide a preliminary metabolic perspective on immunotherapy response and warrant validation in larger patient cohorts.<\/jats:p>","DOI":"10.1007\/s12311-026-02025-y","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:35:20Z","timestamp":1779240920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Case Report of Reversible Mitochondrial Bioenergetic Dysfunction in PBMCs in Anti-GAD65\u2013Associated Cerebellar Ataxia"],"prefix":"10.1007","volume":"25","author":[{"given":"Nat\u00e1lia","family":"Hu\u0148arov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea I\u017earik","family":"Vere\u0161pejov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Gr\u00f3fik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160tefan","family":"Siv\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egon","family":"Kur\u010da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kol\u00edsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"Sk\u00e1\u010dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"10","key":"2025_CR1","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.3390\/ijms21103701","volume":"21","author":"M Dade","year":"2020","unstructured":"Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY, et al. Neurological syndromes associated with anti-GAD antibodies. Int J Mol Sci. 2020;21(10):3701. https:\/\/doi.org\/10.3390\/ijms21103701.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2025_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14802\/jmd.20040","volume":"14","author":"H Mitoma","year":"2021","unstructured":"Mitoma H, Manto M, Hadjivassiliou M. Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms. J Mov Disord. 2021;14(1):10\u201328. https:\/\/doi.org\/10.14802\/jmd.20040.","journal-title":"J Mov Disord"},{"key":"2025_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40673-015-0034-y","volume":"2","author":"H Mitoma","year":"2015","unstructured":"Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias. 2015;2:14. https:\/\/doi.org\/10.1186\/s40673-015-0034-y.","journal-title":"Cerebellum Ataxias"},{"issue":"1","key":"2025_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01927-1","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu T, Liu CH, Lei M, Zeng Q, Li L, Tang H, et al. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther. 2024;9(1):268. https:\/\/doi.org\/10.1038\/s41392-024-01927-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2025_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/ars.2013.5429","volume":"21","author":"E Doherty","year":"2014","unstructured":"Doherty E, Oaks Z, Perl A. Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus. Antioxid Redox Signal. 2014;21(1):56\u201365. https:\/\/doi.org\/10.1089\/ars.2013.5429.","journal-title":"Antioxid Redox Signal"},{"issue":"8006","key":"2025_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07193-7","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti L, Willis CM, Krzak G, Hamel R, Pirvan L, Ionescu RB, et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature. 2024;628(8006):195\u2013203. https:\/\/doi.org\/10.1038\/s41586-024-07193-7.","journal-title":"Nature"},{"key":"2025_CR7","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1007\/s00415-022-11253-1","volume":"269","author":"T Bogdan","year":"2022","unstructured":"Bogdan T, Wirth T, Iosif A, et al. Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study. J Neurol. 2022;269:6354\u201365. https:\/\/doi.org\/10.1007\/s00415-022-11253-1.","journal-title":"J Neurol"},{"issue":"8","key":"2025_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","volume":"71","author":"H Ari\u00f1o","year":"2014","unstructured":"Ari\u00f1o H, Gresa-Arribas N, Blanco Y, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71(8):1009\u201316. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1011.","journal-title":"JAMA Neurol"},{"issue":"9","key":"2025_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00415-025-13292-w","volume":"272","author":"S Lee","year":"2025","unstructured":"Lee S, Kim S, Jin B, et al. Predictive clinical factors for the progression from idiopathic late-onset cerebellar ataxia to multiple system atrophy cerebellar type. J Neurol. 2025;272(9):561. https:\/\/doi.org\/10.1007\/s00415-025-13292-w.","journal-title":"J Neurol"},{"issue":"6","key":"2025_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, et al. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022;37(6):1131\u201348. https:\/\/doi.org\/10.1002\/mds.29005.","journal-title":"Mov Disord"},{"key":"2025_CR11","doi-asserted-by":"publisher","first-page":"8454532","DOI":"10.1155\/2020\/8454532","volume":"2020","author":"SO Seneviratne","year":"2020","unstructured":"Seneviratne SO, Buzzard KA, Cruse B, Monif M. Cerebellar ataxia followed by stiff person syndrome in a patient with anti-GAD antibodies. Case Rep Immunol. 2020;2020:8454532. https:\/\/doi.org\/10.1155\/2020\/8454532.","journal-title":"Case Rep Immunol"},{"key":"2025_CR12","doi-asserted-by":"publisher","DOI":"10.5603\/pjnns.110088","author":"P Skacik","year":"2026","unstructured":"Skacik P, Kurca E, Sivak S. Clinical and genetic characteristics of CANVAS patients: a single-center experience. Neurol Neurochir Pol. 2026. https:\/\/doi.org\/10.5603\/pjnns.110088.","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"2025_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neucli.2015.12.006","volume":"46","author":"L Liang","year":"2016","unstructured":"Liang L, Chen T, Wu Y. The electrophysiology of spinocerebellar ataxias. Neurophysiol Clin. 2016;46(1):27\u201334. https:\/\/doi.org\/10.1016\/j.neucli.2015.12.006.","journal-title":"Neurophysiol Clin"},{"issue":"2","key":"2025_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/ICB.0000000000001543","volume":"19","author":"RM Shah","year":"2025","unstructured":"Shah RM, Maloney MH, Gilbert AL, Patel AP, Vora RA. Autoimmune retinopathy in a patient with stiff-person syndrome: a case report. Retin Cases Brief Rep. 2025;19(2):139\u201344. https:\/\/doi.org\/10.1097\/ICB.0000000000001543.","journal-title":"Retin Cases Brief Rep"},{"key":"2025_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-36955-2","volume-title":"Clinical evoked potentials: an illustrated manual","author":"ON Markand","year":"2020","unstructured":"Markand ON. Clinical evoked potentials: an illustrated manual. Cham: Springer; 2020. https:\/\/doi.org\/10.1007\/978-3-030-36955-2."},{"issue":"10","key":"2025_CR16","doi-asserted-by":"publisher","first-page":"166481","DOI":"10.1016\/j.bbadis.2022.166481","volume":"1868","author":"AM Casey","year":"2022","unstructured":"Casey AM, Murphy MP. Uncovering the source of mitochondrial superoxide in pro-inflammatory macrophages: insights from immunometabolism. Biochim Biophys Acta Mol Basis Dis. 2022;1868(10):166481. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166481.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"2025_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167(2):457\u201370. https:\/\/doi.org\/10.1016\/j.cell.2016.08.064.","journal-title":"Cell"},{"key":"2025_CR18","doi-asserted-by":"publisher","first-page":"101424","DOI":"10.1016\/j.molmet.2022.101424","volume":"57","author":"U Stifel","year":"2022","unstructured":"Stifel U, Wolfschmitt EM, Vogt J, Wachter U, Vettorazzi S, Tews D, et al. Glucocorticoids coordinate macrophage metabolism through regulation of the tricarboxylic acid cycle. Mol Metab. 2022;57:101424. https:\/\/doi.org\/10.1016\/j.molmet.2022.101424.","journal-title":"Mol Metab"},{"key":"2025_CR19","doi-asserted-by":"publisher","first-page":"1676550","DOI":"10.3389\/fimmu.2025.1676550","volume":"16","author":"M Macleod","year":"2025","unstructured":"Macleod M, Pradana F, Wadley AJ, Barlow J. Comprehensive real-time metabolic profiling of peripheral blood mononuclear cells reveals important methodological considerations for immunometabolism research. Front Immunol. 2025;16:1676550. https:\/\/doi.org\/10.3389\/fimmu.2025.1676550.","journal-title":"Front Immunol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02025-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02025-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02025-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:26:20Z","timestamp":1780460780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-026-02025-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02025-y","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted in accordance with the Declaration of Helsinki and approved by the institutional ethics committee of Jessenius Faculty of Medicine in Martin (Approval No. EK 32\/2023). Written informed consent was obtained from the patient to participate. The patient provided written informed consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors utilized ChatGPT 5.2 (OpenAI, GPT-based large language model) and Google built-in AI tool solely for language editing to improve grammar and stylistic fluency. The final scientific content, data interpretation, and conclusions remain the sole responsibility of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations of AI Use"}},{"value":"Clinical trial number: not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}}],"article-number":"83"}}